GH Research to Present at TD Cowen Neuropsychiatry Summit
Ticker: GHRS · Form: 6-K · Filed: Sep 12, 2025 · CIK: 1855129
Sentiment: neutral
Topics: conference-participation, neuropsychiatry, epilepsy
TL;DR
GH Research is speaking at the TD Cowen Neuropsychiatry Summit Sept 17-18, 2025.
AI Summary
GH Research PLC announced its participation in the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry and Epilepsy Summit. The company will present during a fireside chat at the virtual summit, scheduled for September 17-18, 2025. This event provides a platform for GH Research to discuss its developments in the field.
Why It Matters
Participation in industry conferences like this allows GH Research to showcase its progress and engage with the scientific and investment community, potentially impacting its visibility and valuation.
Risk Assessment
Risk Level: low — This filing is an announcement of participation in a conference, which typically carries low risk.
Key Players & Entities
- GH Research PLC (company) — Registrant
- TD Cowen (company) — Organizer of the summit
- September 17-18, 2025 (date) — Dates of the summit
FAQ
What is the specific topic of the fireside chat GH Research PLC will present?
The filing does not specify the exact topic of the fireside chat, only that GH Research PLC will participate in one.
What is the primary focus of the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry and Epilepsy Summit?
The summit focuses on novel mechanisms in neuropsychiatry and epilepsy.
Is the TD Cowen summit being held in person or virtually?
The summit is scheduled to take place virtually.
What is GH Research PLC's filing history regarding annual reports?
GH Research PLC indicates it files annual reports under cover of Form 20-F.
Where is GH Research PLC's principal executive office located?
GH Research PLC's principal executive office is located at Joshua Dawson House, Dawson Street, Dublin 2, D02 RY95, Ireland.
Filing Stats: 185 words · 1 min read · ~1 pages · Grade level 15.9 · Accepted 2025-09-12 07:00:27
Filing Documents
- ef20055467_6k.htm (6-K) — 7KB
- 0001140361-25-034761.txt ( ) — 8KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2025. Commission File Number: 001-40530 GH Research PLC (Exact name of registrant as specified in its charter) Joshua Dawson House Dawson Street Dublin 2 D02 RY95 Ireland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F GH Research PLC will participate in a fireside chat, which will be accessible to those registered to attend the summit, during the TD Cowen 5 th Annual Novel Mechanisms in Neuropsychiatry and Epilepsy Summit, which is scheduled to take place virtually from September 17-18, 2025. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GH Research PLC Date: September 12, 2025 By: /s/ Julie Ryan Name: Julie Ryan Title: Vice President, Finance